Program Indication Discovery IND Approval Phase I Phase II

AND017 (HIF-PHI)
Anemia

Phase II FDA Approval on Jan 14 2021


AND019(SERD)
Breast Cancer

Phase I FDA Approval on Oct 1 2021


ADC
Cancers

Pre-Clinical


AND021
Renal Cell Carcinoma

Pre- Clinical